Tickers

1. Composite Trajectory Verdict

Given BLBD's capital-intensive manufacturing model with significant working capital cycles and debt obligations, all three statements carry roughly equal weight: the income statement shows margin expansion, the cash flow statement captures conversion volatility, and the balance sheet reflects deleveraging and liquidity buildup.

Composite Trajectory: Improving

Annual results show consistent improvement across the three-year period FY2023–FY2025. Revenue grew 18.9% then 9.9% (10-K FY2025, Consolidated Statements of Operations). Gross margin expanded from 12.3% to 19.0% to 20.5% (10-K FY2025, MD&A). Operating margin rose from 4.6% to 10.3% to 11.3% (10-K FY2025, Consolidated Statements of Operations). Net income increased from $23.8M to $105.5M to $127.7M (10-K FY2025, Consolidated Statements of Operations). The balance sheet strengthened markedly: cash rose from $79.0M to $127.7M to $229.3M, long-term debt fell from $95.0M to $85.3M (net of deferred financing), and equity grew from $159.6M to $255.4M (10-K FY2025, Consolidated Balance Sheets). Cash flow from operations dipped in FY2024 ($111.1M vs $119.9M) but rebounded strongly in FY2025 to $176.2M (10-K FY2025, Consolidated Statements of Cash Flows). The only countervailing signal is the FY2024 cash flow dip, which reversed fully in FY2025.

2. Red Flags

• SG&A growing faster than revenue: SG&A as a percentage of net sales increased from 7.7% (FY2023) to 8.7% (FY2024) to 9.2% (FY2025) (10-K FY2025, Consolidated Statements of Operations).
• Working capital volatility: Accounts receivable swung from $59.1M (Sept 2024) to $20.7M (Sept 2025) while inventory rose from $127.8M to $139.5M and accounts payable from $143.2M to $151.5M (10-K FY2025, Consolidated Balance Sheets). The 10-K attributes the AR drop to collection of fleet receivables from FY2024 (10-K FY2025, MD&A, Cash Flows).
• Large non-recurring items in Q3 FY2026: A $160.5M gain from remeasuring the Micro Bird equity investment, a $19.6M pension settlement loss, and $7.2M acquisition costs distorted net income and other income (10-Q 2026-06-27, MD&A, Other income (expense), net).
• Clean Bus Solutions impairment: $7.4M non-cash impairment recorded in FY2025, reducing the carrying value to $0 (10-K FY2025, Note 17).
• Pension plan termination in progress: Projected benefit obligation of $109.6M at Sept 27, 2025 expected to be settled in FY2026 via lump sums and annuity purchases (10-K FY2025, Note 16).
• Backlog fluctuation: Type C/D backlog fell from ~4,800 units (Sept 2024) to ~3,070 units (Sept 2025) then rose to ~3,570 Type C/D + ~1,290 Type A/commercial units (June 2026) (10-K FY2025, MD&A; 10-Q 2026-06-27, Business Update).
• Tariff and supply chain uncertainty: Management states changes in trade policies and tariffs increased procurement costs in second half FY2025 and first nine months FY2026, with risk of future margin impact if price increases cannot offset costs (10-K FY2025, MD&A; 10-Q 2026-06-27, Business Update).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Overall Assessment: Across three full fiscal years, every GAAP profitability metric improved. Net sales rose from $1,132.8M (FY2023) to $1,347.2M (FY2024) to $1,480.1M (FY2025) (10-K FY2025, Consolidated Statements of Operations). Gross profit grew from $138.9M (12.3% margin) to $256.2M (19.0%) to $303.5M (20.5%) (10-K FY2025, Consolidated Statements of Operations). Operating profit increased from $51.7M (4.6% margin) to $139.3M (10.3%) to $167.2M (11.3%) (10-K FY2025, Consolidated Statements of Operations). Net income climbed from $23.8M to $105.5M to $127.7M (10-K FY2025, Consolidated Statements of Operations). Interest expense declined each year: $18.0M → $10.6M → $7.2M (10-K FY2025, Consolidated Statements of Operations). The nine-month FY2026 period shows legacy Blue Bird revenue roughly flat (+0.9%) with gross margin stable at ~20.4% (10-Q 2026-06-27, MD&A), but only one quarterly YoY comparison is available, so the quarterly trend is not separately assessed.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Overall Assessment: Operating cash flow fell from $119.9M (FY2023) to $111.1M (FY2024) then jumped to $176.2M (FY2025) (10-K FY2025, Consolidated Statements of Cash Flows). The FY2024 decline was driven by a $84.1M negative swing in working capital (AR +$46.5M use, AP +$22.0M smaller source, accrued liabilities +$15.9M smaller source) (10-K FY2025, MD&A, Cash Flows). The FY2025 rebound reflected a $22.2M higher net income and a $28.9M positive working capital swing, notably an $85.0M AR collection (10-K FY2025, MD&A, Cash Flows). Free cash flow (non-GAAP) followed the same pattern: $111.4M → $95.8M → $153.3M (10-K FY2025, MD&A, Free cash flow). Capital expenditures rose steadily: $8.5M → $15.3M → $22.9M (10-K FY2025, Consolidated Statements of Cash Flows). With only two YoY comparisons (FY2024 vs FY2023 down, FY2025 vs FY2024 up), the annual cash flow trajectory is mixed.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Overall Assessment: The balance sheet strengthened materially over the two most recent year-ends. Cash and equivalents grew from $79.0M (Sept 2023) to $127.7M (Sept 2024) to $229.3M (Sept 2025) (10-K FY2025, Consolidated Balance Sheets). Total assets increased from $524.9M to $625.3M (10-K FY2025, Consolidated Balance Sheets). Term loan principal (net of deferred financing) declined from $95.0M to $90.3M (10-K FY2025, Note 8). The revolving credit facility remained undrawn at both year-ends with $141.7M available at Sept 2025 (10-K FY2025, Note 8). Stockholders' equity surged from $159.6M to $255.4M, driven by retained earnings accumulation ($0 to $88.2M) and APIC growth ($186.0M to $195.5M) (10-K FY2025, Consolidated Statements of Stockholders' Equity). The Total Net Leverage Ratio (TNLR) priced at Level I (<1.00x) as of Sept 2025, down from Level III at the November 2023 closing (10-K FY2025, Note 8). Current assets rose from $323.4M to $411.6M while current liabilities were nearly flat at $236.8M vs $236.0M (10-K FY2025, Consolidated Balance Sheets).

6. Data Gaps

• Quarterly GAAP income statement, cash flow, and balance sheet data for Q1 FY2026, Q2 FY2026, and Q4 FY2025 (only Q3 FY2026 and nine-month FY2026 are provided in the 10-Q 2026-06-27 filing; the other 10-Qs listed in the prompt do not have their financial statement contents included in the provided text)
• Standalone Q4 FY2025 results (cannot be derived by subtraction per instructions)
• Segment-level cash flow statements
• Detailed breakdown of SG&A components beyond share-based compensation, labor, and R&D mentioned in MD&A
• FY2026 full-year results (not yet filed)
• Historical quarterly trends prior to Q3 FY2025 (only one YoY quarterly comparison available)